Clinical trials
Pulmonary Disease, Chronic Obstructive trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
140 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 4 |
| 2006 | 8 |
| 2007 | 6 |
| 2008 | 5 |
| 2009 | 12 |
| 2010 | 7 |
| 2011 | 14 |
| 2012 | 8 |
| 2013 | 8 |
| 2014 | 16 |
| 2015 | 10 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 8 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 126 |
| Unknown status | 5 |
| Recruiting | 3 |
| Terminated | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 40 |
| AstraZeneca | 23 |
| Boehringer Ingelheim | 20 |
| Novartis Pharmaceuticals | 9 |
| Eurasian Association of Therapists | 4 |
| Novartis | 4 |
| Pearl Therapeutics, Inc. | 4 |
| Sanofi | 4 |
| Chiesi Farmaceutici S.p.A. | 3 |
| I.M. Sechenov First Moscow State Medical University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Disease, Chronic Obstructive | 140 |
| Asthma | 9 |
| Diabetes Mellitus | 5 |
| COVID-19 | 4 |
| Obesity | 4 |
| Atrial Fibrillation | 3 |
| Bronchiolitis Obliterans Syndrome | 3 |
| Bronchitis | 3 |
| Cardiovascular Diseases | 3 |
| Coronary Disease | 3 |
Trials
Showing 26 to 50 of 140. Each trial links to its page on Pharma Observatory.
40 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.